Josep Mallolas

9PUBLICATIONS
34CO-AUTHORS
Equity and trusts lawNanotoxicology, health and safetyBehavioural epidemiologyPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 11, 2026
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study.

|May 07, 2026
Atypical HBV Serological Patterns After Switching to CAB/RPV: Interpretation Within Current Definitions.

|Apr 02, 2026
Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.

Alberto Foncillas, Juan Ambrosioni, Lorena de la Mora

|Mar 09, 2026
Changes in Cellular Senescence Biomarkers Across Individuals at Different Stages of HIV Infection Before and After a Year on Antiretroviral Therapy.

Rubén Ayala-Suárez, Andrea Rodríguez-Agustín, María José Maleno

|Jan 15, 2026
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.

Alberto Foncillas, Juan Ambrosioni, Abiu Sempere

|Dec 24, 2025
Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort.

Alexy Inciarte, Celia Miralles, Ana Silva-Klug

Pageof 2

Frequent Collaborators

6 joint publications

Montserrat Laguno

6 joint publications

Ana Gonzalez-Cordón

5 joint publications

Elisa de Lazzari

5 joint publications

Alberto Foncillas